Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wilson X Wang

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
JAMA Ophthalmology|May 23, 2024
Interventions for Proliferative VitreoretinopathyWilson X Wang, Maggie Xing, Rajendra S Apte
Ophthalmic Surgery, Lasers & Imaging Retina|May 1, 2024
Proliferative Diabetic Retinopathy in PregnancyWilson X Wang, Howard F Fine, Rajendra S Apte
Academic Medicine : Journal of the Association of American Medical Colleges|February 21, 2026
Learner-level-specific considerations in morning report: a scoping reviewJustin Q Wang, Wilson X Wang, Jaclyn Morales, et al.
Journal of Vitreoretinal Diseases|June 8, 2026
Clinical Outcomes and Predictors of Retinal Breaks in Patients With Vitreous Hemorrhage Secondary to a Posterior Vitreous DetachmentHenok Getahun, Cory N Sharp, Kenta Kato, et al.
Ophthalmology. Retina|May 16, 2024
Multimodal Structural and Functional Characterization of Retinal Vasculopathy with Cerebral LeukoencephalopathyWilson X Wang, Aaditya V Shah, Brent Bruck, et al.
International Journal of Ophthalmology|August 29, 2025
Pars plana vitrectomy with tissue plasminogen activator for traumatic submacular hemorrhageWilson X Wang, Kishan G Patel, Henok Getahun, et al.
Ophthalmology Science|September 2, 2025
Retrospective OCT Analysis of Sphingosine-1-Phosphate Modulator Fingolimod in Multiple SclerosisWilson X Wang, Helen Rossmiller, Henok Getahun, et al.
The Journal of Clinical Investigation|December 16, 2024
Crizanlizumab for retinal vasculopathy with cerebral leukoencephalopathy in a phase II clinical studyWilson X Wang, Dan Spiegelman, P Kumar Rao, et al.
The Journal of Clinical Investigation|July 1, 2024
Crizanlizumab for retinal vasculopathy with cerebral leukoencephalopathy in a phase II clinical studyWilson X Wang, Dan Spiegelman, P Kumar Rao, et al.
Frontiers in Neurology|December 25, 2025
Longitudinal association of retinal morphology and white matter progression in retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestationsHenok Getahun, Rajendra S Apte, Wilson X Wang, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
JAMA Ophthalmology|May 23, 2024
Interventions for Proliferative VitreoretinopathyWilson X Wang, Maggie Xing, Rajendra S Apte
Ophthalmic Surgery, Lasers & Imaging Retina|May 1, 2024
Proliferative Diabetic Retinopathy in PregnancyWilson X Wang, Howard F Fine, Rajendra S Apte
Academic Medicine : Journal of the Association of American Medical Colleges|February 21, 2026
Learner-level-specific considerations in morning report: a scoping reviewJustin Q Wang, Wilson X Wang, Jaclyn Morales, et al.
Journal of Vitreoretinal Diseases|June 8, 2026
Clinical Outcomes and Predictors of Retinal Breaks in Patients With Vitreous Hemorrhage Secondary to a Posterior Vitreous DetachmentHenok Getahun, Cory N Sharp, Kenta Kato, et al.
Ophthalmology. Retina|May 16, 2024
Multimodal Structural and Functional Characterization of Retinal Vasculopathy with Cerebral LeukoencephalopathyWilson X Wang, Aaditya V Shah, Brent Bruck, et al.
International Journal of Ophthalmology|August 29, 2025
Pars plana vitrectomy with tissue plasminogen activator for traumatic submacular hemorrhageWilson X Wang, Kishan G Patel, Henok Getahun, et al.
Ophthalmology Science|September 2, 2025
Retrospective OCT Analysis of Sphingosine-1-Phosphate Modulator Fingolimod in Multiple SclerosisWilson X Wang, Helen Rossmiller, Henok Getahun, et al.
The Journal of Clinical Investigation|December 16, 2024
Crizanlizumab for retinal vasculopathy with cerebral leukoencephalopathy in a phase II clinical studyWilson X Wang, Dan Spiegelman, P Kumar Rao, et al.
The Journal of Clinical Investigation|July 1, 2024
Crizanlizumab for retinal vasculopathy with cerebral leukoencephalopathy in a phase II clinical studyWilson X Wang, Dan Spiegelman, P Kumar Rao, et al.
Frontiers in Neurology|December 25, 2025
Longitudinal association of retinal morphology and white matter progression in retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestationsHenok Getahun, Rajendra S Apte, Wilson X Wang, et al.
Pageof 1